Nalaganje...
Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database
BACKGROUND: Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding. The objective of this study is to determine the relative risk of cardiovascular adverse events or haemorrhages in patients with peripheral artery disease treated with cilostazol...
Shranjeno v:
| izdano v: | BMC Cardiovasc Disord |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5941464/ https://ncbi.nlm.nih.gov/pubmed/29739318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0822-4 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|